Exhausmed
Exhausmed is a French health-data software company that sells subscription-based medical device and medication databases, a proprietary medical device ontology, and a hospital BI platform to hospitals, clinics, city practitioners, and industrial partners across three continents.
- Company typePrivate
- Founded2007
- HeadquartersSaint-maur-des-fossés, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Exhausmed does
Exhausmed is a privately held French health-data software company, founded in 2007 and headquartered in Saint-maur-des-fossés, France, with operations in France and on three continents. The company builds and maintains a curated database of medical devices and medications, sold on a subscription basis to three customer segments: healthcare centers (hospitals, clinics, and GHT groupings), industrial partners (medical device manufacturers and software editors), and city-based healthcare professionals. The product suite is anchored by DMPro (medical device database for healthcare centers), DMPro Ville (a variant for city professionals), and Medic (medication database), supported by QualifiData, a data qualification and optimization service.
The platform is differentiated by MEDONTO, a proprietary medical device ontology that provides a structured semantic layer across the database products and the HubHA Business Intelligence platform aimed at GHT and clinic groupings. The technology stack is therefore database-, ontology-, and BI-centric rather than AI-centric, and the underlying data asset is built and maintained in-house by a multidisciplinary team that includes pharmacists and database engineers. This combination of clinical and technical expertise is a defining feature of the offering.
Go-to-market is B2B and sales-led, with direct sales to healthcare institutions and an indirect channel through industrial partners and software editors who embed Exhausmed data into their own healthcare software products. The company offers a free one-week trial of its tools, and revenue is generated through recurring subscriptions. Exhausmed is bootstrapped, with no external funding rounds or investors disclosed, and operates with 11-50 employees. The business model emphasizes long-term institutional contracts with French and international hospital systems, where the database, ontology, and BI products function as reference and analytics infrastructure for medical device management, regulatory compliance, and purchasing decisions.
Exhausmed firmographics
Firmographics- Name
- Exhausmed
- Legal name
- Exhausmed
- Website
- https://[email protected]
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Exhausmed is a French health-data software company that sells subscription-based medical device and medication databases, a proprietary medical device ontology, and a hospital BI platform to hospitals, clinics, city practitioners, and industrial partners across three continents.
- Ownership category
- akta.pro rank
Exhausmed industry classification
Industry- Product category
- Healthcare Data Management Software
- NAICS
- Software Publishers (5132)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO)
- akta.pro secondary industry
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)
Keywords
Where Exhausmed is headquartered
LocationHeadquarters
- HQ city
- Saint-maur-des-fossés
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Exhausmed business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Database Subscription Access: Access to healthcare product databases (medical devices and medications) on a subscription basis. Customers gain access to platforms including DMPro, Medic, QualifiData, Hub-HA, and Medonto for managing and analyzing health product information.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Trial Period |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels1 record
Exhausmed product offering
Product offeringCore offering
Exhausmed develops and licenses subscription-based databases and business intelligence platforms that consolidate information on medical devices and medications marketed in France, serving hospitals, clinics (GHT groupings), and city healthcare professionals. Its portfolio includes DMPro and DMPro Ville device databases, the Medic drug database, the QualifiData data qualification solution, the Hub-HA purchasing BI hub, and the MEDONTO medical device ontology used to structure and integrate device data.
Product overview
Exhausmed offers a platform-plus-products architecture centered on healthcare data management solutions for hospitals and clinics in France. The portfolio includes DMPro and DMPro Ville (medical device databases), Medic (drug database), QualifiData (data qualification), HubHA (Business Intelligence for purchasing), and MEDONTO (Medical Device Ontology for structured data/referentials). These products serve healthcare centers, industrial suppliers, and city-based healthcare professionals by providing information databases, BI analytics, and data structuring tools that simplify professional practice and support strategic purchasing decisions.
Differentiator
Problem solved
Functional benefit
Brands
- DMPro: Database for medical devices information, serving care centers
- DMPro Ville
- Medic
- QualifiData
- HubHA
- Medonto
Products and services
- DMPro Medical device database providing market data, device tracing, and technico-regulatory information for healthcare centers (hospitals and clinics) in France.
- DMPro Ville Variant of DMPro providing city-based healthcare professionals with access to medical device information and documentation for ambulatory daily practice.
- Medic Complete medication database with technico-regulatory information for drugs marketed in France, presented in an innovative format to simplify daily professional practice.
- QualifiData Data qualification and optimization engine for building a reliable, complete, and structured product article database to support strategic decision-making.
- Hub-HA Business Intelligence platform for GHT (hospital territory groupings) or clinic groupings to monitor consumption and purchasing and improve procurement performance.
- MEDONTO Medical Device Ontology that integrates multiple device data sources, reference materials, databases, and classifications to structure device information and enable interoperability with hospital software and procurement platforms.
Companies that use Exhausmed
Customer profileSegments3 records
Ideal customer profiles3 records
Exhausmed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Exhausmed partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Exhausmed competitors and assessment
Company assessmentBroad incumbents
- Cegedim: Cegedim is a major French healthcare-IT incumbent offering physician software, drug databases, and pharma CRM solutions, overlapping with Exhausmed's database and BI offerings from a broader, established position.
- Dedalus Group: Dedalus is a large European hospital-IT vendor whose software suites can embed drug and medical-device reference content, competing for hospital IT budgets alongside Exhausmed's databases and HubHA BI.
- Elsevier (ClinicalKey, Drug Information): Elsevier publishes clinical decision-support and drug reference content for hospitals and clinicians, comparable to Exhausmed's reference data and clinical information products at a global scale.
- Wolters Kluwer (UpToDate, Medi-Span, Clinical Solutions): Wolters Kluwer publishes clinical drug reference content and decision-support tools globally; its Medi-Span and clinical solution lines overlap directly with Exhausmed's subscription drug-reference and BI offerings.
Direct peers
- First Databank (FDB): FDB provides drug knowledge databases (MedKnowledge, OrderMind) used by hospitals and EHR systems, directly comparable to Exhausmed's Medic medication database and QualifiData content layer.
- Vidal: Vidal is the dominant French drug reference database providing technico-regulatory medication information to healthcare professionals, directly comparable to Exhausmed's Medic product in the same French market.
Regional players
- Maincare Solutions: Maincare Solutions is a French hospital-IT vendor serving French hospitals and GHTs with information systems and decision-support modules, overlapping with Exhausmed's GHT purchasing BI (HubHA) footprint.
Emerging players
- GMDN Agency: GMDN Agency maintains the Global Medical Device Nomenclature used to classify medical devices, conceptually overlapping with Exhausmed's MEDONTO ontology which structures French medical-device data.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Exhausmed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exhausmed leadership team
Management profileNumber of profiles
Exhausmed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exhausmed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exhausmed
What does Exhausmed do?
Exhausmed develops and licenses subscription-based databases and business intelligence platforms that consolidate information on medical devices and medications marketed in France, serving hospitals, clinics (GHT groupings), and city healthcare professionals. Its portfolio includes DMPro and DMPro Ville device databases, the Medic drug database, the QualifiData data qualification solution, the Hub-HA purchasing BI hub, and the MEDONTO medical device ontology used to structure and integrate device data.
Is Exhausmed a public or private company?
Exhausmed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Exhausmed founded?
Exhausmed was founded in 2007. It employs 11 to 50 people.
Where is Exhausmed based?
Exhausmed is headquartered in Saint-maur-des-fossés, France, in the Europe region.
How does Exhausmed make money?
One revenue line is on record: database Subscription Access.
Who are Exhausmed's main competitors?
Broad incumbents on record are Cegedim, Dedalus Group, Elsevier (ClinicalKey, Drug Information) and Wolters Kluwer (UpToDate, Medi-Span, Clinical Solutions). Direct peers are First Databank (FDB) and Vidal. Maincare Solutions is listed as a regional player. GMDN Agency is listed as an emerging player.
Does Exhausmed have an API?
No public API is recorded for Exhausmed.
What industry is Exhausmed in?
Exhausmed's product category is Healthcare Data Management Software. Its primary akta.pro industry code is HLACAKAO, Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP), with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 5132 and its SIC code is 3841.